Trupanion (NASDAQ:TRUP) Releases Earnings Results, Misses Estimates By $0.01 EPS

Trupanion (NASDAQ:TRUP) issued its earnings results on Thursday. The financial services provider reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01), FiscalAI reports. Trupanion had a return on equity of 4.48% and a net margin of 1.10%.The firm had revenue of $376.85 million for the quarter, compared to analyst estimates of $375.89 million.

Trupanion Stock Performance

TRUP stock traded down $0.19 during midday trading on Thursday, hitting $32.14. The company’s stock had a trading volume of 900,728 shares, compared to its average volume of 438,015. The stock has a market cap of $1.39 billion, a price-to-earnings ratio of 89.28 and a beta of 1.58. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.31. The stock’s 50-day moving average price is $35.14 and its 200 day moving average price is $40.30. Trupanion has a 1 year low of $30.54 and a 1 year high of $57.88.

Analyst Upgrades and Downgrades

TRUP has been the topic of a number of recent research reports. Wall Street Zen lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Cantor Fitzgerald lowered their target price on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating on the stock in a report on Wednesday, January 14th. Piper Sandler cut their price target on Trupanion from $67.00 to $60.00 and set an “overweight” rating for the company in a research note on Friday, December 19th. Stifel Nicolaus decreased their price objective on Trupanion from $42.00 to $38.00 and set a “hold” rating for the company in a report on Thursday, January 29th. Finally, Zacks Research raised Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 6th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $50.00.

Insider Activity

In related news, CEO Margaret Tooth sold 9,605 shares of the business’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $37.88, for a total value of $363,837.40. Following the transaction, the chief executive officer directly owned 150,294 shares of the company’s stock, valued at approximately $5,693,136.72. The trade was a 6.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Fawwad Qureshi sold 6,202 shares of the stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $35.45, for a total transaction of $219,860.90. The SEC filing for this sale provides additional information. Insiders sold a total of 32,853 shares of company stock valued at $1,181,863 in the last ninety days. 5.42% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Trupanion

Hedge funds have recently modified their holdings of the stock. Kelleher Financial Advisors bought a new position in Trupanion during the third quarter valued at $74,000. Advisory Services Network LLC bought a new stake in shares of Trupanion in the third quarter valued at $160,000. Tidal Investments LLC purchased a new position in shares of Trupanion during the 2nd quarter valued at $212,000. Renaissance Technologies LLC bought a new position in shares of Trupanion during the 4th quarter worth $224,000. Finally, Brevan Howard Capital Management LP purchased a new stake in Trupanion in the 2nd quarter worth about $236,000.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.